1. Home
  2. VRDN vs SONO Comparison

VRDN vs SONO Comparison

Compare VRDN & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • SONO
  • Stock Information
  • Founded
  • VRDN 2006
  • SONO 2002
  • Country
  • VRDN United States
  • SONO United States
  • Employees
  • VRDN N/A
  • SONO N/A
  • Industry
  • VRDN Medical Specialities
  • SONO Consumer Electronics/Video Chains
  • Sector
  • VRDN Health Care
  • SONO Consumer Discretionary
  • Exchange
  • VRDN Nasdaq
  • SONO Nasdaq
  • Market Cap
  • VRDN 1.6B
  • SONO 1.7B
  • IPO Year
  • VRDN N/A
  • SONO 2018
  • Fundamental
  • Price
  • VRDN $16.27
  • SONO $11.93
  • Analyst Decision
  • VRDN Buy
  • SONO Buy
  • Analyst Count
  • VRDN 12
  • SONO 2
  • Target Price
  • VRDN $36.44
  • SONO $14.50
  • AVG Volume (30 Days)
  • VRDN 979.5K
  • SONO 2.3M
  • Earning Date
  • VRDN 03-04-2025
  • SONO 02-06-2025
  • Dividend Yield
  • VRDN N/A
  • SONO N/A
  • EPS Growth
  • VRDN N/A
  • SONO N/A
  • EPS
  • VRDN N/A
  • SONO N/A
  • Revenue
  • VRDN $302,000.00
  • SONO $1,456,044,000.00
  • Revenue This Year
  • VRDN $3.30
  • SONO N/A
  • Revenue Next Year
  • VRDN N/A
  • SONO $8.89
  • P/E Ratio
  • VRDN N/A
  • SONO N/A
  • Revenue Growth
  • VRDN N/A
  • SONO N/A
  • 52 Week Low
  • VRDN $11.40
  • SONO $10.23
  • 52 Week High
  • VRDN $27.20
  • SONO $19.76
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 36.43
  • SONO 28.58
  • Support Level
  • VRDN $15.62
  • SONO $12.75
  • Resistance Level
  • VRDN $18.15
  • SONO $13.38
  • Average True Range (ATR)
  • VRDN 0.91
  • SONO 0.65
  • MACD
  • VRDN -0.20
  • SONO -0.19
  • Stochastic Oscillator
  • VRDN 14.48
  • SONO 1.40

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: